Pediatrix Medical Group (NYSE:MD) Shares Gap Up - Still a Buy?

Pediatrix Medical Group, Inc. (NYSE:MD - Get Free Report)'s share price gapped up prior to trading on Friday . The stock had previously closed at $12.32, but opened at $13.80. Pediatrix Medical Group shares last traded at $13.58, with a volume of 49,088 shares trading hands.

Analysts Set New Price Targets

Several research analysts have weighed in on MD shares. StockNews.com upgraded shares of Pediatrix Medical Group from a "sell" rating to a "hold" rating in a report on Wednesday, August 7th. Truist Financial lifted their price target on Pediatrix Medical Group from $10.00 to $13.00 and gave the stock a "hold" rating in a report on Monday, October 7th. Jefferies Financial Group raised Pediatrix Medical Group from a "hold" rating to a "buy" rating and raised their target price for the company from $8.00 to $14.00 in a research report on Thursday, September 26th. Finally, UBS Group boosted their price target on shares of Pediatrix Medical Group from $9.00 to $10.50 and gave the stock a "neutral" rating in a report on Friday, August 9th. Five research analysts have rated the stock with a hold rating and one has issued a buy rating to the company. According to MarketBeat.com, the company presently has a consensus rating of "Hold" and a consensus target price of $10.90.

Pediatrix Medical Group Stock Up 23.5 %

The firm has a market cap of $1.31 billion, a P/E ratio of -5.02, a price-to-earnings-growth ratio of 1.96 and a beta of 1.56. The stock's fifty day moving average is $11.54 and its two-hundred day moving average is $9.36. The company has a current ratio of 1.38, a quick ratio of 1.38 and a debt-to-equity ratio of 0.87.

Pediatrix Medical Group (NYSE:MD - Get Free Report) last announced its earnings results on Tuesday, August 6th. The company reported $0.34 earnings per share for the quarter, beating analysts' consensus estimates of $0.31 by $0.03. The business had revenue of $504.30 million for the quarter, compared to the consensus estimate of $505.49 million. Pediatrix Medical Group had a negative net margin of 12.58% and a positive return on equity of 10.59%. Pediatrix Medical Group's quarterly revenue was up .7% on a year-over-year basis. During the same period last year, the firm posted $0.37 earnings per share. As a group, research analysts anticipate that Pediatrix Medical Group, Inc. will post 1.19 earnings per share for the current year.

Insider Activity

In other Pediatrix Medical Group news, Director Laura A. Linynsky sold 7,000 shares of the business's stock in a transaction that occurred on Tuesday, August 27th. The stock was sold at an average price of $11.16, for a total value of $78,120.00. Following the completion of the sale, the director now owns 30,805 shares in the company, valued at approximately $343,783.80. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. In related news, CEO James D. Swift sold 11,100 shares of the business's stock in a transaction dated Friday, August 30th. The shares were sold at an average price of $10.79, for a total transaction of $119,769.00. Following the sale, the chief executive officer now owns 170,001 shares of the company's stock, valued at $1,834,310.79. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, Director Laura A. Linynsky sold 7,000 shares of the firm's stock in a transaction that occurred on Tuesday, August 27th. The shares were sold at an average price of $11.16, for a total transaction of $78,120.00. Following the transaction, the director now directly owns 30,805 shares of the company's stock, valued at $343,783.80. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders sold 68,100 shares of company stock valued at $701,889. Corporate insiders own 2.00% of the company's stock.

Hedge Funds Weigh In On Pediatrix Medical Group

Several large investors have recently modified their holdings of MD. Principal Financial Group Inc. raised its holdings in Pediatrix Medical Group by 14.1% in the 3rd quarter. Principal Financial Group Inc. now owns 513,618 shares of the company's stock worth $5,953,000 after acquiring an additional 63,581 shares during the last quarter. Nisa Investment Advisors LLC raised its stake in shares of Pediatrix Medical Group by 352.4% in the third quarter. Nisa Investment Advisors LLC now owns 21,513 shares of the company's stock worth $249,000 after purchasing an additional 16,758 shares during the last quarter. Everence Capital Management Inc. purchased a new position in shares of Pediatrix Medical Group in the third quarter worth $149,000. Creative Planning lifted its holdings in shares of Pediatrix Medical Group by 48.3% during the third quarter. Creative Planning now owns 30,662 shares of the company's stock valued at $355,000 after purchasing an additional 9,991 shares in the last quarter. Finally, CWM LLC increased its holdings in Pediatrix Medical Group by 134.0% in the 3rd quarter. CWM LLC now owns 6,427 shares of the company's stock worth $74,000 after buying an additional 3,681 shares in the last quarter. Hedge funds and other institutional investors own 97.71% of the company's stock.

Pediatrix Medical Group Company Profile

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.